ID

43618

Descripción

Trastuzumab in Treating Women With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00896376

Link

https://clinicaltrials.gov/show/NCT00896376

Palabras clave

Versiones (2)
  1. 18/1/17 18/1/17 -
  2. 20/9/21 20/9/21 -
Subido en

20 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00896376

Inglés

Eligibility Breast Cancer NCT00896376

1 formularios  
Criteria
Descripción

Criteria

histologically confirmed breast cancer
Descripción

Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
metastatic disease, defined by the existence of a secondary tumor localization radiologically (i.e., by radiography, ct scan, mri scan, or ultrasound) or scintigraphically confrimed
Descripción

Neoplasm Metastasis | Secondary Neoplasm Localization Diagnostic radiologic examination | Radiography | CT scan | MRI Scan | Ultrasonography | Scintigraphy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2,1]
C2939419
UMLS CUI [2,2]
C0475264
UMLS CUI [2,3]
C0043299
UMLS CUI [3]
C0034571
UMLS CUI [4]
C0040405
UMLS CUI [5]
C0917711
UMLS CUI [6]
C0041618
UMLS CUI [7]
C0034606
evaluable disease
Descripción

Evaluable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1516986
beginning first-line metastatic treatment with trastuzumab (herceptin®) with or without chemotherapy
Descripción

First line treatment Neoplasm Metastasis | trastuzumab | Herceptin | Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0027627
UMLS CUI [2]
C0728747
UMLS CUI [3]
C0338204
UMLS CUI [4]
C0392920
primary tumor must overexpress her2 (ihc 3+ or ihc 2+ and fish+ or fish+)
Descripción

primary tumor | ERBB2 Protein Overexpression Immunohistochemistry | Fluorescent in Situ Hybridization

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0677930
UMLS CUI [2,1]
C1515560
UMLS CUI [2,2]
C0021044
UMLS CUI [3]
C0162789
hormone receptor status not specified
Descripción

Hormone Receptor Status Unspecified

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205370
no brain metastasis
Descripción

Metastatic malignant neoplasm to brain

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0220650
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
menopausal status not specified
Descripción

Menopausal Status Unspecified

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3829127
UMLS CUI [1,2]
C0205370
life expectancy > 3 months
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
able to undergo cardiotoxicity evaluation every 4 months by measuring lvef via an isotopic method or ultrasound with systematic registration
Descripción

Cardiotoxicity Evaluation Frequency | Left ventricular ejection fraction Isotopic | Ultrasonography

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0876994
UMLS CUI [1,2]
C1261322
UMLS CUI [1,3]
C0376249
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C4038403
UMLS CUI [3]
C0041618
no chronic uncontrolled disease
Descripción

Chronic disease Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0205318
no heart failure
Descripción

Heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018801
no respiratory failure or hypoxemia
Descripción

Respiratory Failure | Hypoxemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1145670
UMLS CUI [2]
C0700292
no history of another primary cancer except for basal cell carcinoma of the skin
Descripción

Primary malignant neoplasm | Basal cell carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1306459
UMLS CUI [2]
C0007117
no severe uncontrolled infection
Descripción

Communicable Disease Uncontrolled Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0205082
no psychological incapacity
Descripción

Mental impairment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0683322
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Descripción

disease characteristic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0599878
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00896376

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Breast Carcinoma
Item
histologically confirmed breast cancer
boolean
C0678222 (UMLS CUI [1])
Neoplasm Metastasis | Secondary Neoplasm Localization Diagnostic radiologic examination | Radiography | CT scan | MRI Scan | Ultrasonography | Scintigraphy
Item
metastatic disease, defined by the existence of a secondary tumor localization radiologically (i.e., by radiography, ct scan, mri scan, or ultrasound) or scintigraphically confrimed
boolean
C0027627 (UMLS CUI [1])
C2939419 (UMLS CUI [2,1])
C0475264 (UMLS CUI [2,2])
C0043299 (UMLS CUI [2,3])
C0034571 (UMLS CUI [3])
C0040405 (UMLS CUI [4])
C0917711 (UMLS CUI [5])
C0041618 (UMLS CUI [6])
C0034606 (UMLS CUI [7])
Evaluable Disease
Item
evaluable disease
boolean
C1516986 (UMLS CUI [1])
First line treatment Neoplasm Metastasis | trastuzumab | Herceptin | Chemotherapy
Item
beginning first-line metastatic treatment with trastuzumab (herceptin®) with or without chemotherapy
boolean
C1708063 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0728747 (UMLS CUI [2])
C0338204 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
primary tumor | ERBB2 Protein Overexpression Immunohistochemistry | Fluorescent in Situ Hybridization
Item
primary tumor must overexpress her2 (ihc 3+ or ihc 2+ and fish+ or fish+)
boolean
C0677930 (UMLS CUI [1])
C1515560 (UMLS CUI [2,1])
C0021044 (UMLS CUI [2,2])
C0162789 (UMLS CUI [3])
Hormone Receptor Status Unspecified
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain
Item
no brain metastasis
boolean
C0220650 (UMLS CUI [1])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Menopausal Status Unspecified
Item
menopausal status not specified
boolean
C3829127 (UMLS CUI [1,1])
C0205370 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
Cardiotoxicity Evaluation Frequency | Left ventricular ejection fraction Isotopic | Ultrasonography
Item
able to undergo cardiotoxicity evaluation every 4 months by measuring lvef via an isotopic method or ultrasound with systematic registration
boolean
C0876994 (UMLS CUI [1,1])
C1261322 (UMLS CUI [1,2])
C0376249 (UMLS CUI [1,3])
C0428772 (UMLS CUI [2,1])
C4038403 (UMLS CUI [2,2])
C0041618 (UMLS CUI [3])
Chronic disease Uncontrolled
Item
no chronic uncontrolled disease
boolean
C0008679 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Heart failure
Item
no heart failure
boolean
C0018801 (UMLS CUI [1])
Respiratory Failure | Hypoxemia
Item
no respiratory failure or hypoxemia
boolean
C1145670 (UMLS CUI [1])
C0700292 (UMLS CUI [2])
Primary malignant neoplasm | Basal cell carcinoma
Item
no history of another primary cancer except for basal cell carcinoma of the skin
boolean
C1306459 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
Communicable Disease Uncontrolled Severe
Item
no severe uncontrolled infection
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Mental impairment
Item
no psychological incapacity
boolean
C0683322 (UMLS CUI [1])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
disease characteristic
Item
see disease characteristics
boolean
C0599878 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial